Anika Therapeutics Inc. is a leader in joint preservation and regenerative therapies, focusing on innovative orthopedic treatments to enhance patient mobility and alleviate pain. Headquartered in Bedford, Massachusetts, the company operates globally, with a strong presence in the United States and Europe. Anika's product portfolio includes advanced hyaluronic acid-based therapeutics that address the needs of patients with osteoarthritis and other joint disorders, positioning the company for growth in the expanding musculoskeletal market. With a commitment to research and development, Anika aims to drive advancements in minimally invasive procedures and improve patient outcomes through cutting-edge solutions.